Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Karn WijarnpreechaCharat ThongprayoonSupavit ChesdachaiPanadeekarn PanjawatananaPatompong UngprasertWisit CheungpasitpornPublished in: Digestive diseases and sciences (2017)
Our study demonstrates statistically significant 1.3-fold increased risks of CKD and ESRD in patients using PPIs, but not in patients using H2RAs.